Bristol-Myers Squibb Co (NYSE:BMY)
| 64.81 Delayed Data As of May 14 |  -0.07 / -0.11%Today’s Change | 54.07 Today|||52-Week Range 67.16 | +4.48% Year-to-Date |
Latest BMY News | Press Releases
Today’s Trading
| Previous close | 64.88 |
| Today’s open | 65.18 |
| Day’s range | 64.62 - 65.23 |
| Volume | 7,555,502 |
| Average volume (3 months) | 12,193,952 |
| Market cap | $143.9B |
Data as of 4:23pm ET, 05/14/2021
Growth & Valuation
| Earnings growth (last year) | -297.94% |
| Earnings growth (this year) | +15.97% |
| Earnings growth (next 5 years) | +6.92% |
| Revenue growth (last year) | +62.62% |
| P/E ratio | NM |
| Price/Sales | 3.29 |
| Price/Book | 3.82 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AZNAstraZeneca | +0.16 | +0.29% |
| NVONovo Nordisk | -0.03 | -0.04% |
| SNYSanofi | +0.19 | +0.36% |
| LLYEli Lilly and Co | +0.14 | +0.07% |
Data as of 4:00pm ET, 05/14/2021
Financials
| Next reporting date | July 29, 2021 |
| EPS forecast (this quarter) | $1.91 |
| Annual revenue (last year) | $42.5B |
| Annual profit (last year) | -$9.0B |
| Net profit margin | -21.20% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
